Press Releases Biocon Limited

Equities

BIOCON

INE376G01013

Delayed NSE India S.E. Other stock markets 12:52:50 2024-05-02 am EDT			5-day change	1st Jan Change
303.7 ^INR	+1.73%		+8.33%	+21.57%

Apr. 30	Natural Biocon (India) CFO Passes Away	MT
Apr. 20	Biocon Limited Receives Approval from the South African Health Products Regulatory Authority for its Vertically Integrated, Complex Drug Product Tacrolimus Capsule 0.5mg, 1mg and 5mg Strengths, in South Africa	CI

Press Releases

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Biocon is the first generics company to obtain approval for diabetes drug, Liraglutide, in the U.K.	Mar. 28	AQ
Updates On Aflibercept BPCIA Litigation	Mar. 26	AQ
Biocon Biologics Secures US Market Entry Date for Bmab 1200, a Proposed Biosimilar to Stelara	Mar. 01	AQ
PTAB Institutes Celltrion And Biocon IPRs On Regeneron Aflibercept Dosing Patent	Feb. 29	AQ
Biocon Included in S&P Global Sustainability Yearbook 2024	Feb. 21	AQ
Biocon Q3FY24 Revenue at Rs 4,519 Cr, Up 50%, Biosimilars Up 65%, Research Services Up 9%, EBITDA at Rs 1,492 Cr, Up 106%, Net Profit at Rs 660 Cr Pre-Paid USD 200 Mn towards Debt Reduction	Feb. 09	AQ
Biocon Biologics Partners with Sandoz Australia for Biosimilars Trastuzumab and Bevacizumab	Feb. 08	AQ
Biocon Limited - Oral Cancer Task Force's Consensus Guidelines for Head and Neck Cancer Recognized among 13 Worldwide Clinical Practice Guidelines	Feb. 06	AQ
Biocon Academy Conducts its 8th Graduation Day	Dec. 20	AQ
Biocon Biologics Recognized as an Asia IP Elite for 2023, IPR Team adjudged as the Team of the Year	Dec. 18	AQ
Biocon Biologics Successfully Completes Integration of Viatris' Biosimilar Business in 31 Countries in Europe	Nov. 30	AQ
Biocon Biologics Successfully Completes Integration of Viatris’ Biosimilar Business in 31 Countries in Europe	Nov. 30	GL
Biocon Ltd - EdelGive and Hurun India recognizes Kiran Mazumdar-Shaw as the Second most generous women philanthropist in India	Nov. 10	AQ
Biocon Biologics Announces Divestment of Two Non-Core Branded Formulations, India Business Units	Nov. 09	AQ
Biocon Biologics Continues to Expand Global Footprint, Completes Integration of Viatris Biosimilars Business in North America, Ahead of Schedule	23-09-07	AQ
Biocon Biologics Continues to Expand Global Footprint, Completes Integration of Viatris Biosimilars' Business In North America Ahead of Schedule	23-09-06	AQ
Biocon Limited announces the acquisition of a manufacturing facility of Eywa Pharma Inc.	23-09-04	AQ
Biocon Foundation and Shakti Sustainable Energy Foundation organize Cities and Climate Action Workshop	23-08-10	AQ
Biocon Biologics Announces Key Leadership Appointments	23-08-07	AQ
Post-Trial Briefing In Regeneron v. Mylan Aflibercept BPCIA Case Now Complete	23-08-03	AQ

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Press Releases Biocon Limited

Equities

BIOCON

INE376G01013

Press Releases

Filters